Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WGAS bottom in!!! Up now we go!!!
Just out from Gerald:
We are making solid progress in the first quarter by:
1.Streamlining our financial structure: As many development-stage companies born in the chaos of 2008, we suffered through financial hardship while we worked to establish proof-of-concept for MANF in Parkinson’s disease. Since that time, we have taken concrete steps to clean-up our balance sheet, a critical move to fund the further development of MANF and our diagnostic platforms. In the last two weeks, the Company has retired a number of potentially problematic notes, warrants and legal challenges that would have otherwise impeded our continued development, and makes us a much healthier company.
2.Spinning off Amarantus Diagnostics: Last week we disclosed the creation of Amarantus Diagnostics, a subsidiary company to further develop the Company’s LymPro and NuroPro diagnostic assets. The internal estimates of the market opportunity for these assets exceeds $800 million and the time to market is likely significantly less than our MANF asset, due to different regulatory requirements for marketing of these types of diagnostics. Moreover, with recent guidance from the FDA regarding the need to focus drug development programs on early-stage patients, Amarantus Diagnostics will be positioned among the most innovative companies developing products in the Alzheimer’s space with LymPro. From the corporate perspective, we believe we can unlock the true value of these assets without further diluting the value of the MANF opportunity for our shareholders with this strategy. We are currently working on updating the clinical trial design for the LymPro and NuroPro assets in light of recent developments in the field and will update the marketplace in the near future regarding timelines to key milestones on their path to commercialization. At that time, we will also address how our shareholders will benefit from the spinoff.
3.MANF entering the eye of the storm: 2013 has been characterized by many in our industry as the year of the growth factor in Parkinson’s Disease. For those who do not know the history, several hundred million dollars were spent in the 1990’s and early 2000’s researching the translation of certain neurotrophic factors into new treatments for patients. While those efforts ended in failure, the knowledge gained from those endeavors, particularly as it relates to delivery of therapeutics to the brain, has shaped a new wave of growth factor treatments currently in development. Amarantus owns the patent rights to both protein therapy and gene therapy for MANF in all neurological indications including Parkinson’s, uniquely positioning the Company from an intellectual property standpoint. What’s more, MANF’s ability to cause re-innervation of the striatum with nigral delivery separates it as a best-in-class molecule from a mechanism standpoint. In the coming months, we expect other biotech companies to announce clinical data outcomes on biological approaches, and we believe this will result in increased interest in the field overall. We view this as a very significant benefit to Amarantus, and we are positioning ourselves to capitalize on the increased focus these trial results will bring with them.
Management is working closely with our Board of Advisors to finalize the product development plans for MANF and deliver key timelines and milestones on the road to an IND filing for MANF in Parkinson’s disease and we will update the marketplace in this regard once the planning has been finalized. We believe that significant milestones will be achievable in parallel as the Company generates additional data on other indications for MANF, with a specific focus on orphan diseases. Going forward, we will continue to aggregate data in our Parkinson’s program and bolster our intellectual property portfolio for MANF in other indications. With a market opportunity that we estimate to exceed $5 billion annually, we believe this is the best way to maximize the value of MANF at this critical phase in its product development cycle, as well as strategically position Amarantus to capitalize on various opportunities that are in best interest of the Company and our shareholders.
We’re very excited about the direction of Amarantus and look forward to updating shareholders on additional progress in the coming weeks.
Warmest Regards,
Gerald E. Commissiong
President & Chief Executive Officer
Amarantus BioScience, Inc. (AMBS) Stock info Amarantus Bioscience Inc. 0.075 -0.007
Today 5d 1m 3m 1y 5y 10y
Amarantus BioScience, Inc. (Verified links) Official Website:
www.amarantus.com
Official Social Media:
Twitter: www.twitter.com/AmarantusBio
Facebook: www.facebook.com/amarantusbio
LinkedIN: www.linkedin.com/company/amarantus-biosciences
Google+: plus.google.com/110152688579338796390
YouTube: http://www.youtube.com/user/Amarantus2011
Other Official Links-
Development :
AMRS001
Parkinson’s Disease
Cardiac Ischemia.
Press Releases:
Press Releases & News Articles
Verified Contacts-
Company Headquarters
Amarantus BioScience, Inc.
c/o The Parkinson's Institute
675 Almanor Ave
Sunnyvale, CA 94085
Tel: 408-737-2734
Fax: (408) 852-4427
Press Contact:
pr[at]Amarantus[dot]com
408-737-2734 x102
Hoping for that 4 P.M. press release...Go JALA!
Got me some 15's!! holding for 30's ++++
Yeah! Are you still getting JALA 15's?
Cool Thanks!! Go GWBU!!!
CDFT beasting today!!! Looking forward to Friday's pic!!!
promo going on psc and squawkbox stocks...
I've lost all my trust in promoters after being RARSd and VLNXd and GWBUd. Good luck to those who remain, hope it goes to the Moon for you.
I got out at .0202. I didn't make much though cause I had old shares from being RARSd last year... Well today was fun...
Got out of RARS at .0202 don't know if it will keep going!
You see what's happening? Go RARS!!!!!
Yeah baby!!!
WHY haven't they put a press realease concerning their android version. Are we waiting for a big promo? Come on RARS!
Cool maybe its time for rars to go parabolic!!!! Imo
Dreamers we are...breakout board here we come...
Did i say thanks?
Thanks Garyst so far im doing tons better this year playing some of your plays and my own but not being greedy. On wgas and Entb i took a little profit but left behind some free shares just in case they continue rising. Thanks for the encouragement to stay away from promos and be happy with 20%. I think this will be a great year.
Thanks Garyst so far im doing tons better this year playing some of your plays and my own but not being greedy. On wgas and Entb i took a little profit but left behind some free shares just in case they continue rising. Thanks for the encouragement to stay away from promos and be happy with 20%. I think this will be a great year.
I felt better about getting into ENTB I'm glad I did, excellent day. Now I have some more money for the next pick here. Hope everyone here gets their 20 on tuesday.
Penny today? Maybe...
ENTB moving today. .0051 +18.6% now!!!!
I can't believe it it hit 2's. I finally sold my 1's after waiting forever... Good Luck Y'all
What about ENTB? It's sister company BMSN sky rocketed the last few days over a penny, I think ENTB will do the same.
BMSN still going!!!
What a bomb FUEG is today...
I hope so...damaged goods here...will I ever get anything back out of this...?
Crazy trading to start the morning off, now nothing... Come on people let's get this going back up...
MWIP up 20.2% now...I wish I had some moola to get it...
I was hoping to get my 20% out of AMBS, or BMSN today so I could put a little more in MWIP, but so far no go. I've decided just putting $100 in something, it's too hard to make enough after commissions. I did it with ERBB but it took a while... Good Luck GG you get out of Scarebuilder yet?
Maybe Victorypennystocks is not part of VM? I dont see it in Teffys IBOX. I thought it was:
Here's my email yesterday:
Hello Everyone,
Get ready for our new MONSTER alert!
Our new pick will be released tomorrow morning.
We are expecting a very strong performance from this company and we want our members to get in early and profit!
Make sure that you are checking your e-mail inboxes.
We promise this will be worth your time and you will want to research this company as soon as we alert it!
Your VictoryPennyStocks Editor